GPT-Rosalind (OpenAI) vs Perplexity AI
Which one should you pick? Here's the full breakdown.
GPT-Rosalind (OpenAI)
OpenAI's first domain-specific model -- life sciences, drug discovery, translational medicine. Launched 2026-04-16 as a Trusted Access research preview. Launch partners: Amgen, Moderna, Allen Institute, Thermo Fisher. Paired with a Life Sciences Codex plugin (50+ scientific tool integrations)
Perplexity AI
AI-powered search engine that gives cited answers instead of a list of links
| Category | GPT-Rosalind (OpenAI) | Perplexity AI |
|---|---|---|
| Ease of Use | 3.0 | 9.0 |
| Output Quality | 9.0 | 8.0 |
| Value | 7.0 | 9.0 |
| Features | 8.0 | 8.0 |
| Overall | 6.8 | 8.5 |
Pricing Comparison
| Feature | GPT-Rosalind (OpenAI) | Perplexity AI |
|---|---|---|
| Free Tier | No | Yes |
| Starting Price | Invite only | $0 |
Which Should You Pick?
Pick GPT-Rosalind (OpenAI) if...
- ✓Higher output quality (9 vs 8)
Researchers and enterprises in biology, drug discovery, protein science, translational medicine, or adjacent life-sciences domains who can get Trusted Access. Also relevant to anyone building life-sciences AI products who needs to understand where OpenAI's vertical strategy is heading.
Visit GPT-Rosalind (OpenAI)Pick Perplexity AI if...
- ✓Easier to use (9 vs 3)
- ✓Better value for money (9/10)
- ✓Has a free tier
Researchers, students, professionals, and anyone who needs factual answers with sources. It's what Google should have become.
Visit Perplexity AIOur Verdict
Perplexity AI is the clear winner here with 8.5/10 vs 6.8/10. GPT-Rosalind (OpenAI) isn't bad, but Perplexity AI outperforms it across the board. Pick GPT-Rosalind (OpenAI) only if researchers and enterprises in biology, drug discovery, protein science, translational medicine, or adjacent life-sciences domains who can get trusted access.